Genomic surveillance of SARS-CoV-2 in Nepal
- PMID: 39530702
- PMCID: PMC11636318
- DOI: 10.1128/mra.00789-24
Genomic surveillance of SARS-CoV-2 in Nepal
Abstract
During the COVID-19 pandemic, Nepal, like other countries, faced emerging SARS-CoV-2 variants. To evaluate the circulating variants, 278 samples collected between September 2021 and March 2022 were sequenced in the country. From these, 229 high-quality genomes were obtained (82.97% Omicron and 17.03% Delta) highlighting the genomic diversity of SARS-CoV-2 in Nepal.
Keywords: COVID-19; Illumina; coronavirus; whole-genome sequencing.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Rayamajhee B, Pokhrel A, Syangtan G, Khadka S, Lama B, Rawal LB, Mehata S, Mishra SK, Pokhrel R, Yadav UN. 2021. How well the government of Nepal is responding to COVID-19? An experience from a resource-limited country to confront unprecedented pandemic. Front Public Health 9:597808. doi:10.3389/fpubh.2021.597808 - DOI - PMC - PubMed
-
- Wilm A, Aw PPK, Bertrand D, Yeo GHT, Ong SH, Wong CH, Khor CC, Petric R, Hibberd ML, Nagarajan N. 2012. LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets. Nucleic Acids Res 40:11189–11201. doi:10.1093/nar/gks918 - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
